Selexys Pharmaceuticals Corporation
Latest round
- Series A
Last raised
- Sep 2012
Total raised
- $24M
Investors
- 1
About Selexys Pharmaceuticals Corporation
Selexys Pharmaceuticals Corporation develops investigational therapies aimed at treating hematological disorders.740 mn.Selexys specializes in innovative biopharmaceutical products for hematological conditions, particularly focusing on sickle cell disease. Their primary product is an investigational therapy that employs advanced molecular technology to alleviate the frequency of painful crises in patients. The therapy interacts with specific cellular pathways to mitigate debilitating symptoms, thereby improving patients' quality of life.Selexys generates revenue through direct-to-consumer sales and partnerships with healthcare providers and research institutions. Its business model is based on offering its investigational therapy via clinical trials and subsequent commercialization, ensuring patient access. Revenue comes from one-time therapy purchases and ongoing agreements with healthcare systems for patient access programs. The company aims to advance its investigational therapy towards commercialization, with potential new products designed to meet patient needs in hematological conditions. Selexys is also targeting expansion into additional markets, particularly within Europe and certain Asian regions, to increase access to its therapies. The acquisition offer from Novartis will further strengthen the company’s resources to support these growth initiatives.
Who invested in Selexys Pharmaceuticals Corporation
1 investor across 1 round
See all investors in Selexys Pharmaceuticals Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 19, 2012
Amount
$24M
Investors
Questions about Selexys Pharmaceuticals Corporation
Who invested in Selexys Pharmaceuticals Corporation?
Selexys Pharmaceuticals Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Selexys Pharmaceuticals Corporation raised?
Selexys Pharmaceuticals Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Selexys Pharmaceuticals Corporation last raise money?
Selexys Pharmaceuticals Corporation's most recent round on record is a Series A, in Sep 2012.
What does Selexys Pharmaceuticals Corporation do?
Selexys Pharmaceuticals Corporation develops investigational therapies aimed at treating hematological disorders.
Where is Selexys Pharmaceuticals Corporation headquartered?
Selexys Pharmaceuticals Corporation is headquartered in Oklahoma City, US.
Which VCs invest in companies like Selexys Pharmaceuticals Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Selexys Pharmaceuticals Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Selexys Pharmaceuticals Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.